Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) EBT Margin: 2009-2020

Historic EBT Margin for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to 156.56%.

  • Avadel Pharmaceuticals' EBT Margin rose 65259.00% to 156.56% in Q4 2020 from the same period last year, while for Dec 2020 it was 24.54%, marking a year-over-year increase of 16198.00%. This contributed to the annual value of -82.52% for FY2020, which is 5492.00% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported EBT Margin of 156.56% as of Q4 2020, which was down 69.53% from 513.75% recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' EBT Margin ranged from a high of 513.75% in Q3 2020 and a low of -496.03% during Q4 2019.
  • In the last 3 years, Avadel Pharmaceuticals' EBT Margin had a median value of -45.17% in 2019 and averaged -19.45%.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' EBT Margin slumped by 1,105,654bps in 2016, and later spiked by 65,259bps in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' EBT Margin (Quarterly) stood at 41.96% in 2016, then plummeted by 5,833bps to -16.36% in 2017, then crashed by 35,836bps to -374.72% in 2018, then slumped by 12,131bps to -496.03% in 2019, then soared by 65,259bps to 156.56% in 2020.
  • Its last three reported values are 156.56% in Q4 2020, 513.75% for Q3 2020, and 358.40% during Q2 2020.